Sowell Financial Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
8,906
+813
+10% +$153K 0.06% 351
2026
Q1
$1.6M Sell
8,093
-444
-5% -$85.6K 0.06% 344
2025
Q4
$1.57M Sell
8,537
-671
-7% -$118K 0.06% 328
2025
Q3
$1.41M Buy
9,208
+932
+11% +$141K 0.05% 349
2025
Q2
$1.16M Buy
8,276
+116
+1% +$16.3K 0.05% 377
2025
Q1
$1.2M Buy
8,160
+328
+4% +$47.5K 0.05% 342
2024
Q4
$1.03M Buy
+7,832
New +$1.1M 0.05% 307
2023
Q3
Sell
-6,699
Closed -$959K 512
2023
Q2
$959K Buy
6,699
+2,229
+50% +$328K 0.05% 365
2023
Q1
$621K Sell
4,470
-1,016
-19% -$137K 0.05% 400
2022
Q4
$744K Buy
+5,486
New +$688K 0.05% 364
2022
Q1
Sell
-5,113
Closed -$596K 193
2021
Q4
$596K Buy
+5,113
New +$602K 0.03% 411
2021
Q2
Sell
-4,361
Closed -$466K 715
2021
Q1
$466K Sell
4,361
-20,964
-83% -$2.11M 0.02% 670
2020
Q4
$2.61M Buy
25,325
+931
+4% +$98.6K 0.11% 164
2020
Q3
$2.66M Buy
24,394
+21,503
+744% +$2.39M 0.13% 138
2020
Q2
$306K Sell
2,891
-229
-7% -$23.7K 0.02% 589
2020
Q1
$279K Sell
3,120
-104
-3% -$9.79K 0.02% 567
2019
Q4
$321K Sell
3,224
-224
-6% -$21.1K 0.02% 575
2019
Q3
$307K Buy
+3,448
New +$299K 0.03% 530
2017
Q1
Sell
-1,311
Closed -$76K 277
2016
Q4
$76K Buy
+1,311
New +$74.4K 0.03% 292

Other funds holding AZN

Sowell Financial Services's AZN Position: Q2 2026 in Review

Sowell Financial Services increased its AstraZeneca (AZN) stake by 10% in Q2 2026, buying an estimated $153K and bringing the position to 8,906 shares worth $1.69M. The position accounts for 0.06% of the portfolio, ranked #351.

Sowell Financial Services first reported a position in AZN in Q4 2016 and has held it in 19 quarters since. The position peaked at $2.66M in Q3 2020. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Sowell Financial Services held 8,906 shares of AstraZeneca worth $1.69M as of Q2 2026.
  • Sowell Financial Services bought 813 AstraZeneca shares in Q2 2026, an estimated $153K.
  • AstraZeneca made up 0.06% of Sowell Financial Services's portfolio in Q2 2026, its #351 holding.
  • Sowell Financial Services first reported a position in AstraZeneca in Q4 2016 and has held it in 19 quarters since.
  • Sowell Financial Services's AstraZeneca position peaked at $2.66M in Q3 2020.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.